Skip to main content Back to Top
Advertisement

2/18/2020

Chlordiazepoxide Capsules

Products Affected - Description

    • Chlordiazepoxide capsule, Mylan Institutional, 5 mg, unit-dose blister pack, 100 count, NDC 51079-0374-20

Reason for the Shortage

    • Mylan did not provide a reason for the shortage.
    • Teva has chlordiazepoxide capsules available.

Available Products

    • Chlordiazepoxide capsule, Mylan Institutional, 10 mg, unit-dose blister pack, 100 count, NDC 51079-0375-20
    • Chlordiazepoxide capsule, Mylan Institutional, 25 mg, unit-dose blister pack, 100 count, NDC 51079-0141-20
    • Chlordiazepoxide capsule, Teva, 10 mg, bottle, 100 count, NDC 00555-0033-02
    • Chlordiazepoxide capsule, Teva, 10 mg, bottle, 500 count, NDC 00555-0033-05
    • Chlordiazepoxide capsule, Teva, 25 mg, bottle, 100 count, NDC 00555-0159-02
    • Chlordiazepoxide capsule, Teva, 25 mg, bottle, 500 count, NDC 00555-0159-04
    • Chlordiazepoxide capsule, Teva, 5 mg, bottle, 100 count, NDC 00555-0158-02
    • Chlordiazepoxide capsule, Teva, 5 mg, bottle, 500 count, NDC 00555-0158-04

Estimated Resupply Dates

    • Mylan Institutional has chlordiazepoxide 5 mg capsules in 100 count unit-dose packs on back order and the company estimates a release date of mid- to late-February 2020.

Updated

Updated February 18, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 20, 2019 by Rachael Freeman, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins